A treatment for sickle cell disease in a mouse model
description
Transcript of A treatment for sickle cell disease in a mouse model
![Page 1: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/1.jpg)
A treatment for sickle cell disease in a mouse modelGroup A5Laura Plank, Truc Nguyen, Joshua Trinidad, and Peyton Dent
![Page 2: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/2.jpg)
Introduction
• Sickle cell is an autosomal recessive genetic blood disorder with overdominance (Wikipedia).
• The disease is caused by an abnormal hemoglobin, hemoglobin S or HbS.
• BCL11A is a gene that is found in humans and is also found in mice.
• Gene silencing • Inactivating BCL11A
http://www.childrenshospital.org/newsroom/Site1339/mainpageS1339P778.html
![Page 3: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/3.jpg)
Methods •An experiment was setup to observe red
blood cells of three different groups of mice.
•The first group was the control group•The second group contained mice that
had SCD•The third group contained mice with SCD,
but where BCL11A was inactivated.
![Page 4: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/4.jpg)
Data and Results (Xu, et.al.)
http://www.sciencemag.org/content/334/6058/993/F1.large.jpg
![Page 5: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/5.jpg)
Data and Results (Xu, et.al.)
http://www.sciencemag.org/content/334/6058/993/F1.large.jpg
![Page 6: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/6.jpg)
Data and Results (Xu, et.al.)
http://www.sciencemag.org/content/334/6058/993/F3.expansion.html
![Page 7: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/7.jpg)
Discussion
•BCL11A is a transcription factor converting HbF to HbA
•Essential in erythroid maturation•Silencing BCL11A prevents HbF conversion to HbA
•Absence of BCL11A does not affect erythroid maturity
![Page 8: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/8.jpg)
Conclusion
•Gene regulation is important in regards to reversing sickle cell disease through the silencing of BCL11A which reduces the phenotypic expression of SCD.
![Page 9: A treatment for sickle cell disease in a mouse model](https://reader036.fdocuments.us/reader036/viewer/2022062315/568161ac550346895dd16926/html5/thumbnails/9.jpg)
Works Cited• Freeman, Scott. Biological Science. 4th ed. San
Francisco, CA: Benjamin Cummings, 2011. Print • Graham, Rob. "Dialing up fetal hemoglobin dials down
sickle cell disease." Boston Children's Hospital. N.p., 13 2011. Web. 19 Nov 2012.http://www.childrenshospital.org/newsroom/Site1339/mainpageS1339P778.html
• “Sickle-cell disease.” Wikipedia. Web. 19 Nov. 2012.• Xu, Jian, et al. “Correction of Sickle Cell Disease in Adult
Mice by Interference with Fetal Hemoglobin Silencing.” Science 334 (2011): 993-996. Web. 10 Nov. 2012.